Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglasov VF, Stepula VV, Dudov A, Lehmacher W, Mengs U. Semiglasov VF, et al. Among authors: mengs u. Anticancer Res. 2004 Mar-Apr;24(2C):1293-302. Anticancer Res. 2004. PMID: 15154663 Free article. Clinical Trial.
Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
Elsässer-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U. Elsässer-Beile U, et al. Among authors: mengs u. J Urol. 2005 Jul;174(1):76-9. doi: 10.1097/01.ju.0000163261.08619.d0. J Urol. 2005. PMID: 15947582 Clinical Trial.
Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U. Elsässer-Beile U, et al. Among authors: mengs u. Anticancer Res. 2005 Nov-Dec;25(6C):4733-6. Anticancer Res. 2005. PMID: 16334168 Free article. Clinical Trial.
Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.
Elsässer-Beile U, Ruhnau T, Freudenberg N, Wetterauer U, Mengs U. Elsässer-Beile U, et al. Among authors: mengs u. Cancer. 2001 Mar 1;91(5):998-1004. Cancer. 2001. PMID: 11251952
Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF, Stepula VV, Dudov A, Schnitker J, Mengs U. Semiglazov VF, et al. Among authors: mengs u. Anticancer Res. 2006 Mar-Apr;26(2B):1519-29. Anticancer Res. 2006. PMID: 16619567 Free article. Clinical Trial.
Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models.
Burger AM, Mengs U, Schüler JB, Fiebig HH. Burger AM, et al. Among authors: mengs u. Anticancer Res. 2001 May-Jun;21(3B):1965-8. Anticancer Res. 2001. PMID: 11497284
Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.
Dohmen W, Breier M, Mengs U. Dohmen W, et al. Among authors: mengs u. Anticancer Res. 2004 Mar-Apr;24(2C):1231-7. Anticancer Res. 2004. PMID: 15154652 Clinical Trial.
No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.
Burger AM, Mengs U, Kelter G, Schüler JB, Fiebig HH. Burger AM, et al. Among authors: mengs u. Anticancer Res. 2003 Sep-Oct;23(5A):3801-6. Anticancer Res. 2003. PMID: 14666680
Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
Schaffrath B, Mengs U, Schwarz T, Hilgers RD, Beuth J, Möckel B, Lentzen H, Gerstmayer B. Schaffrath B, et al. Among authors: mengs u. Anticancer Res. 2001 Nov-Dec;21(6A):3981-7. Anticancer Res. 2001. PMID: 11911280
[Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
Mengs U, Witthohn K, Schwarz T, Lentzen H. Mengs U, et al. Wien Med Wochenschr. 1999;149(8-10):262-4. Wien Med Wochenschr. 1999. PMID: 10483695 Review. German.
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback